ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Spinogenix Granted FDA Orphan Drug Designation for SPG302 for the Treatment of Amyotrophic Lateral Sclerosis
June 09, 2021Spinogenix, Inc. announced it has been granted Orphan Drug Designation (ODD) for SPG302 in amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) by the U.S. FDA. -
Spinogenix Announces Grant by DOD to Advance ALS Drug Candidate
January 12, 2021Spinogenix will be collaborating with Dr. Rita Sattler at the Barrow Neurological Institute and Dr. Justin Ichida at the USC Keck School of Medicine on a grant awarded from the U.S. Department of Defense’s (DOD) ...
Pharma Sources Insight January 2025
